Beeyond

This topic follows biomedical innovation where research, devices, regulation and care delivery meet, with strong attention to cancer, digital trials, implants and health economics.

A technical watch on coronary intervention, from drug-coated balloons and stents to vascular biology, antiplatelet therapy and next-generation implant materials.

This topic treats the car industry as a live disruption case, linking autonomous driving, China, EV strategy, AI and the restructuring of European automakers.

Consumer digital health is followed through wearables, remote monitoring, digital therapeutics, liability, reimbursement and the hard work of health-system integration.

Track and Trace focuses on pharmaceutical serialization, recalls, packaging errors, FDA audit readiness, RFID, visual inspection and operational risk.

Blue Ocean Strategy supplies the business-framework layer: market creation, value innovation, non-disruptive innovation and practical applications across sectors.

Augmented and virtual reality are followed through AR glasses, enterprise productivity, AI-enabled interfaces, healthcare, retail, culture and real-world deployments.

This oncology topic concentrates on glioblastoma and other hard-to-treat solid tumors, with a strong focus on immunotherapy, biomaterials, local delivery and clinical translation.

Nudges are tracked as both practical behavioral tools and ethical problems, especially in health, adherence, app engagement, hand hygiene and manipulation debates.

Fashion and technology appears as a testing ground for virtual try-on, product passports, RFID, wearables, Web3, sustainability and consumer experience.

Instrumental cosmetics covers beauty as hardware: lasers, microneedling, AI skin analysis, AR retail, injectables, sensing and device-led skincare.

This structural-heart topic follows transcatheter mitral repair and replacement through trials, device milestones, regulatory approvals and outcomes in high-risk patients.

Aston Martin is watched as a luxury brand under pressure, where Formula 1 ambition, road-car engineering, financial stress and turnaround strategy intersect.

Brain-computer interfaces and connected medical devices are followed from neural interfaces and EEG wearables to clinical trials, FDA clearance and real patient use.

Neurovascular Intervention tracks thrombectomy, aneurysm devices, stent and flow-diverter design, biomaterials, regulatory news and trial evidence.

This French-language multiple sclerosis topic focuses on upstream mechanisms such as EBV, genetics, microbiome, myelin repair, cell therapy and prevention.

The community internet topic follows telecom disruption through AI agents, satellite networks, Starlink, spectrum, network economics and post-telco business models.

Aidants brings a social-care dimension, following family caregivers, mental health, ageing, respite, public policy, teleassistance and recognition of unpaid care work.

Diabetes is tracked through GLP-1 drugs, obesity pharmacology, connected insulin devices, continuous glucose monitoring, cardiovascular risk and patient self-management.

This market-intelligence topic reads telecom through Starlink, AI-RAN, tokenized networks, hyperscalers, laser communications and strategic disruption scenarios.

Peritoneal dialysis is followed as a home-care and device topic, combining outcomes, peritonitis detection, telemonitoring, quality of life and program implementation.

The COVID-19 topic follows vaccines, variants, immunity, treatments, safety debates and policy evidence as an evolving science-heavy dossier.

This dormant topic followed the future of e-cigarettes through health risks, youth addiction, harm reduction, disposable-vape regulation and international policy disputes.

In-vitro diagnostics are tracked through liquid biopsy, microfluidics, point-of-care testing, biosensors, non-invasive sampling, regulation and hype control.

CLTI focuses on below-the-knee and peripheral vascular innovation, with drug-coated devices, resorbable scaffolds, trial results and regulatory milestones.

This specialized gene-delivery topic follows local cancer therapy, mesenchymal stem cells, suicide genes, nanoparticles, hydrogels and precision delivery platforms.

Intra-dermal drug delivery is centered on microneedles as a platform for therapy, vaccination, sensing, wound care, skin disease treatment and translational engineering.

Metabolic Activation Therapy tracks pulsatile insulin, artificial pancreas ideas, diabetic complications and a contested therapy narrative around glucose control.